Saccharomyces boulardii CNCM I-745

A non-pathogenic yeast uniquely suited for concurrent administration with antibiotics, offering robust protection against antibiotic-associated diarrhea.

Mechanisms of Action

As a yeast, S. boulardii is inherently resistant to antibacterial antibiotics. It secretes proteases that degrade C. difficile toxins A and B, making it a critical tool in preventing C. difficile-associated diarrhea.

Indication	Standard Dose	Clinical Rating
AAD Prevention	500mg (approx 10x10^9 CFU)	Strong (WGO Guidelines)